Abstract:Background: One of the most common cancers worldwide is hepatocellular carcinoma (HCC). Studies have shown that Hepatitis B virus (HBV) X gene (HBx) mutations play a potentially important oncogenic role in the pathogenesis of this disease. However, the molecular mechanisms underlying the malignant transformation of liver cells following HBV infection are poorly understood. We previously identified a novel deletion mutation in HBx (HBx-d382) that is capable of transforming hepatocytes and increasing their tumorigenic capacity. As part of the afore-mentioned study, we also identified reverse transcriptase enzyme (rt)/s* double mutants in nucleoside analogue (NA)-resistant patients. This current study was conducted to determine if HBx-d382 and rt/s* mutations co-exist in HCC patients. The study also aimed to identify the role of these mutations in HCC. Methods: DNA from serum samples obtained from 152 NA-resistant patients with chronic hepatitis B (CHB) and 33 patients with HCC were sequenced to identify samples harboring both the HBx-d382 mutation and rt/s* double mutations. As part of this study, we also generated lentivirus constructs carrying different HBV mutations including rtA181T/sW172*, rtM204I/sW196*, HBx-d382, rtA181T/sW172*/HBx-d382 and rtM204I/sW196*/HBx-d382. The recombinant viral constructs were used to infect a human hepatocyte cell line (LO2). The LO2 cell line was used to evaluate the effect of the mutations on apoptosis, cellular proliferation and the rate of colony formation in the LO2 cells harboring different mutations. Results: We identified rt/s*/HBx-d382 mutations in both HBV-related HCC and NA-resistant CHB clinical samples and observed that the rate of occurrence of rt/s*/HBx-d382 mutations in HBV-related HCC is relatively high. The results of this study revealed that the rtA181T/sW172* and rtM204I/sW196* double mutants exhibited enhanced proliferation, reduced apoptosis and an increased rate of colony formation in LO2 cells. Expression of p53 and CyclinD1 were increased and the level of p21 was decreased in the rtA181T/sW172* and rtM204I/sW196* expressing LO2 cells. More importantly, rt/s* double mutations combined with the HBx-d382 mutation resulted in more severe phenotypes compared with rt/s* double mutation alone in LO2 cell lines. Conclusions: Our data suggest that rt/s*/HBx-d382 triple mutants play a crucial role in HBV-mediated HCC formation.

Transformation of Human Liver L-O2 Cells Mediated by Stable HBx Transfection.

Progressive Changes in Hepatoma Cells Stably Transfected with Hepatitis B Virus X Gene

Gene Expression Profiles of Human Liver Cells Mediated by Hepatitis B Virus X Protein

Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.

Hepatitis B Virus X Protein in the Proliferation of Hepatocellular Carcinoma Cells

Hepatitis B Virus X Protein (HBx) Suppresses Transcription Factor EB (TFEB) Resulting in Stabilization of Integrin Beta 1 (ITGB1) in Hepatocellular Carcinoma Cells

Molecular Functions and Biological Roles of Hepatitis B Virus X Protein

Stimulation of B7-H1 in Hepatocarcinoma Cells by Hepatitis B Virus X Antigen.

HBx Deletion-Mutant Combined with the Reverse Transcriptase Enzyme/s* Mutation is Involved in HBV Mediated Liver Cell Proliferation and Apoptosis

Effects of Hepatitis B Virus X Protein on the Development of Liver Cancer

Hepatitis B Virus X Protein Accelerates the Development of Hepatoma.

Role of hepatitis B virus X protein in development and progression of primary liver cancer

Effect of Hepatitis B Virus X Protein on the Growth of Liver Cancer Cells

HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway

Mechanisms of HBx Mediated Liver Cancer: Multiple Pathways and Opportunities

Involvement of Hepatitis B Virus X Gene (hbx) Integration in Hepatocarcinogenesis Via a Recombination of HBx/Alu Core Sequence/subtelomeric DNA

Hepatitis B virus X gene transforms human hepatocyte QSG7701 in vitro

[Role of HBx in hepatocellular carcinoma development].

Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras.

Hepatitis B Virus X Protein Promotes Human Hepatoma Cell Growth Via Upregulation of Transcription Factor AP2α and Sphingosine Kinase 1

Ground Glass Hepatocytes Coexpressing Hepatitis B Virus X Protein And Surface Antigens Effect On Oncogenic Effects And Tumorigenesis.